In the past, there have been many attempts to treat stroke by intervention on the peripheral immune system, mainly through the intervention of cytokine receptors, such as TNF-α, IL-1, IL-6 and IL-10 [9], while most of the attempts failed to be translated into clinical application [9]. The gene discussed is IL6; the disease is stroke disorder.